NTAP vs SLNO · P/E 28, rev $6.24B vs P/E 27, $2.76B cap
NetApp Inc (NTAP) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
SLNO does not have a complete income-statement cache yet.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the NTAP and SLNO stock pages for the full models.
Not investment advice.